Ulrich Herfurth
Attorney
Managing Senior Partner of the law firm Herfurth & Partner, www.herfurth.de

Ulrich Herfurth is Senior Partner of Herfurth & Partner in Hannover; his focus is in the range of Corporation Law and Mergers & Acquisitions, Financing, Marketing & Distribution Law as well as Transfer of Technology, particularly with relation to international Law. Ulrich Herfurth also heads the Alliuris Group, www.alliuris.de, with 20 offices and 200 business lawyers in Europe.

Herfurth & Partner is an international business law firm specialized in the areas of international trade and commerce, sales organisations, cooperation and licences, establishment of companies, investment, finance, taxes, real estate and labour law. The firm consists of 20 German and international lawyers in Hannover and four in Munich. Clients are provided by several German-Indian attorneys in a special India Team.

Prof. Dr. Stefan Hockertz
Toxicologist, Pharmacologist, Immunologist
Managing Partner of tpi consult GmbH, www.tpi-consult.de

The former Director of the Institute for Experimental and Clinical Toxicology at the University Medical School Hamburg Eppendorf and Professor at the Hamburg University has served earlier as a Director of the Fraunhofer Institute of Toxicology and Environmental Medicine, Hamburg. He has started his career as an investigator at the Fraunhofer Society in Hannover. Hockertz is a “Eurotox Registered Toxicologist” and a „Herstellungs- and Kontrollleiter“ according to §15.1 and §15.3 of the German Drug Law.

The services of tpi consult GmbH comprise among others support for life science companies in preclinic, safety and drug registration and authorization through scientific advisory or also through interim management, toxicological risk assessments according to the European Guidelines, preparation of Common Technical Documents (CTD) for EMEA and FDA, and organisation and monitoring of clinical studies in oncology.

Prof. Dr. Herbert Jäckle
Chemist and Biologist
Director of the Max-Planck-Institute for Biophysical Chemistry, Göttingen, www.mpibpc.mpg.de/groups/jaeckle

Following his studies at Freiburg University, and research activities in Austin (Texas, USA), Heidelberg, Tübingen and Munich, Herbert Jäckle was appointed by the Max Planck Society to set up the new Department of Molecular Developmental Biology at the MPI of Biophysical Chemistry in Göttingen.

The research of his group is focussed on the molecular processes and mechanisms involved in the phenomenon of biological pattern formation and now extends to other biological aspects like energy homeostasis and organogenesis. Jäckle received a number of prestigious awards and honours, and his expertise is sought by science journals, commissions, and for scientific evaluations. He is author of over 200 scientific publications. Since 2002, Jäckle serves as Vice President of the Max Planck Society.

Prof. Dr. Klaus Reymann
Biologist und Zoologist
Head of the Project group Neuropharmacology of the Leibnitz Institute for Neurobiology, Magdeburg, www.ifn-magdeburg.de, Managing Partner of FAN gGmbH, www.fan-neuroscience.com, a non-profit Research Institute of Applied Neurosciences.

Reymann is a brain researcher with long years of professional experience in the fundamental research of memory mechanisms. From 1990 on, his focus is on applied research in the areas of stroke protection, stem cell transplantation and dementia. He is co-founder of several biotech companies and serves as an expert for different European committees.

FAN gGmbH is active in neuroscientific research with the aim of developing innovative and economically exploitable products in their early stage of added value, as well as contract research under expert’s guidance for the pharmaceutical and biotech industry, especially in the field of preclinical testing of CNS drugs. In collaboration with the Magdeburg University and the Leibnitz Institute for Neurobiology functional magnetic resonance tomography (fMRI) is offered for the investigation of pharmaceutical efficacy.